Dave Hallett is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as Chief Scientific Officer at Recursion and previously at Exscientia. With a strong background in alliance management and chemistry as Executive Vice President at Evotec, Dave also held the position of Research Fellow at Merck. This extensive experience encompasses leadership roles in scientific development and strategic partnerships.